Intestinal failure-associated steatosis and fibroblast growth factor 21 plasma levels among adult chronic intestinal failure patients
Adult CIF patients with steatosis had higher FGF21 plasma levels than CIF patients without steatosis. FGF21 is a good predictor for diagnosing steatosis and has a good correlation with LFC. FGF21 should be considered as a biomarker for steatosis in adult patients with CIF.
Authors
- Julia W Korzilius (ORCID: https://orcid.org/0000-0002-6584-1172)
- Geert Wanten (ORCID: https://orcid.org/0000-0002-5918-5594)
- René te Morsche
- Marinette van der Graaf (ORCID: https://orcid.org/0000-0001-7495-987X)
- Angelique Huijbers (ORCID: https://orcid.org/0000-0002-7194-4602)
Institutions
- Radboud University Nijmegen (NL)
- Radboud University Medical Center (NL)
- Radboud Institute for Molecular Life Sciences (NL)
Publication Details
- Journal
- Clinical Nutrition ESPEN
- Published
- 2025-04-26
- DOI
- https://doi.org/10.1016/j.clnesp.2025.04.017
- Citations
- 1
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.01